Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CA4 | P22748 | 2/20 | 0.62 |
| ▸ | CA6 | P23280 | 2/20 | 0.62 |
| ▸ | CA7 | P43166 | 2/20 | 0.62 |
| ▸ | CA9 | Q16790 | 2/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | CA3 | P07451 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | CA5A | P35218 | 1/20 | 0.62 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | TPMT | P51580 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11774612 | 0.85 | CA12 (0.58) | CA12CA1CA2CA4CA6 | |
| SCHEMBL2937093 | 0.82 | CA12 (0.41) | CA12CA1CA2CA4CA6 | |
| SCHEMBL917818 | 0.82 | MAPT (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4576891 | 0.82 | CA12 (0.41) | CA12CA1CA2CA4CA6 | |
| SCHEMBL10317501 | 0.82 | CA12 (0.60) | CA12CA1CA2CA4CA6 | |
| SCHEMBL29149126 | 0.81 | PTGS2 (0.48) | CA12CA1CA2CA4CA6 | |
| SCHEMBL2937498 | 0.81 | KDM4E (0.58) | CA12CA1CA2CA4CA6 | |
| SCHEMBL31556009 | 0.79 | CA12 (0.56) | CA12CA1CA2CA4CA6 | |
| SCHEMBL4576550 | 0.79 | CXCL12 (0.52) | CA12CA1CA2CA4CA6 | |
| SCHEMBL4576554 | 0.79 | CXCL12 (0.52) | CA12CA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504367-A | Preparation method of benvimod | 承德医学院 | 2025-02-25 | — | — | CN | claimed |
| CN-117105768-A | Preparation method of 4-isopropyl 3, 5-dimethoxy benzoic acid | 承德医学院 | 2023-11-24 | — | — | CN | claimed |
| CN-122029153-A | Aromatic hydrocarbon receptor modulator compound, and preparation method and application thereof | 德明药泰生物技术（深圳）有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260091027-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | THEDERMA SHANGHAI CO LTD (CN) | 2026-04-02 | — | — | US | disclosed |
| EP-4592271-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | Thederma Shanghai Co., Ltd. (CN) | 2025-07-30 | — | — | EP | disclosed |
| WO-2025082312-A1 | AROMATIC HYDROCARBON RECEPTOR MODULATOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 德明药泰生物技术（深圳）有限公司 | 2025-04-24 | — | — | WO | disclosed |
| CN-119504367-A | Preparation method of benvimod | 承德医学院 | 2025-02-25 | — | — | CN | disclosed |
| CN-118317952-A | Heterocyclic substituted phenol derivatives, process for their preparation and their use | 上海泽德曼医药科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118139837-A | Stilbene derivative, preparation method and application thereof | 上海泽德曼医药科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118084629-A | Styrene compound, preparation method and medical application thereof | 上海泽德曼医药科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-116947799-B | Phenolic compound, preparation method and medical application thereof | 上海泽德曼医药科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2024078372-A1 | HETEROCYCLIC SUBSTITUTED PHENOL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海泽德曼医药科技有限公司 | 2024-04-18 | — | — | WO | disclosed |
| WO-2024061187-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 上海泽德曼医药科技有限公司 | 2024-03-28 | — | — | WO | disclosed |
| CN-117447402-A | Aromatic hydrocarbon receptor modulator compound, and preparation method and application thereof | 德明药泰生物技术（深圳）有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117105768-A | Preparation method of 4-isopropyl 3, 5-dimethoxy benzoic acid | 承德医学院 | 2023-11-24 | — | — | CN | disclosed |
| CN-117105768-A | Preparation method of 4-isopropyl 3, 5-dimethoxy benzoic acid | 承德医学院 | 2023-11-24 | — | — | CN | disclosed |
| CN-117105768-A | Preparation method of 4-isopropyl 3, 5-dimethoxy benzoic acid | 承德医学院 | 2023-11-24 | — | — | CN | disclosed |
| CN-116947799-A | Phenolic compound, preparation method and medical application thereof | 上海泽德曼医药科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-111217681-A | Anti-inflammatory compounds and uses thereof | 福州百草堂医药科技有限公司 | 2020-06-02 | — | — | CN | disclosed |
| US-20080255245-A1 | Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxystilbenes and Novel Stilbene Derivatives and Analogues | WELICHEM BIOTECH INC. (CA) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255245-A1 | Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxystilbenes and Novel Stilbene Derivatives and Analogues | NFKBIA, IKBKB, IKBKE | CA12 4789/4885CA1 4802/4885CA2 3883/4885 |
| US-20260091027-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | AHR, CYP1B1, ARNT | CA12 3341/4885CA1 3590/4885CA2 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.